Why the study?
Does the choice of specific inotropic drugs improve clinical or physiological outcomes in adult patients after cardiac surgery?
Does the choice of specific inotropic drugs improve clinical or physiological outcomes in adult patients after cardiac surgery?
There is currently insufficient evidence to recommend one specific inotropic agent over another for adult patients after cardiac surgery, highlighting the need for large clinical trials.
Answers are grounded in this paper and cite their sources.
No inotrope can yet be preferred after cardiac surgery; leaves open the need for head-to-head RCTs to guide selection.
Many adult patients require temporary inotropic support after cardiac surgery. We reviewed the literature systematically to establish, present and classify the evidence regarding choice of inotropic drugs. The available evidence, while limited in quality and scope, supports the following observations; although all beta-agonists can increase cardiac output, the best studied beta-agonist and the one with the most favourable side-effect profile appears to be dobutamine. Dobutamine and phosphodiesterase inhibitors (PDIs) are efficacious inotropic drugs for management of the low cardiac output syndrome. Dobutamine is associated with a greater incidence of tachycardia and tachyarrhythmias, whereas PDIs often require the administration of vasoconstrictors. Other catecholamines have no clear advantages over dobutamine. PDIs increase the likelihood of successful weaning from cardiopulmonary bypass as compared with placebo. There is insufficient evidence that inotropic drugs should be selected for their effects on regional perfusion. PDIs also increase flow through arterial grafts, reduce mean pulmonary artery pressure and improve right heart performance in pulmonary hypertension. Insufficient data exist to allow selection of a specific inotropic agent in preference over another in adult cardiac surgery patients. Multicentre randomized controlled trials focusing on clinical rather than physiological outcomes are needed.
No takes yet. Share an insight, caveat, or question.
Gillies et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: